Abstract

BackgroundTo better understand the complex molecular level interactions seen in the pathogenesis of Alzheimer's disease, the results of the wet-lab and clinical studies can be complemented by mathematical models. Astrocytes are known to become reactive in Alzheimer's disease and their ionic equilibrium can be disturbed by interaction of the released and accumulated transmitters, such as serotonin, and peptides, including amyloid- peptides (A). We have here studied the effects of small amounts of A25–35 fragments on the transmitter-induced calcium signals in astrocytes by Fura-2AM fluorescence measurements and running simulations of the detected calcium signals.Methodology/Principal FindingsIntracellular calcium signals were measured in cultured rat cortical astrocytes following additions of serotonin and glutamate, or either of these transmitters together with A25–35. A25–35 increased the number of astrocytes responding to glutamate and exceedingly increased the magnitude of the serotonin-induced calcium signals. In addition to A25–35-induced effects, the contribution of intracellular calcium stores to calcium signaling was tested. When using higher stimulus frequency, the subsequent calcium peaks after the initial peak were of lower amplitude. This may indicate inadequate filling of the intracellular calcium stores between the stimuli. In order to reproduce the experimental findings, a stochastic computational model was introduced. The model takes into account the major mechanisms known to be involved in calcium signaling in astrocytes. Model simulations confirm the principal experimental findings and show the variability typical for experimental measurements.Conclusions/SignificanceNanomolar A25–35 alone does not cause persistent change in the basal level of calcium in astrocytes. However, even small amounts of A25–35, together with transmitters, can have substantial synergistic effects on intracellular calcium signals. Computational modeling further helps in understanding the mechanisms associated with intracellular calcium oscillations. Modeling the mechanisms is important, as astrocytes have an essential role in regulating the neuronal microenvironment of the central nervous system.

Highlights

  • Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder that leads to cognitive impairment and emotional disturbances

  • Amyloid plaques containing aggregated amyloid-b peptides (Ab) fragments have been shown to disturb the homeostasis of intracellular calcium ions (Ca2z) and contribute to the altered Ca2z signaling in the brain cells [1]

  • We show that Ab25–35 increases the initial peak of Ca2z release when added together with 5-HT, compared to the effects of 5-HT alone

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder that leads to cognitive impairment and emotional disturbances. Amyloid plaques containing aggregated Ab fragments have been shown to disturb the homeostasis of intracellular calcium ions (Ca2z) and contribute to the altered Ca2z signaling in the brain cells [1]. Ab42 and the shorter 11 amino acids long synthetic derivative (Ab25–35) are both fragments which are widely used in Alzheimer’s disease research (see recent studies [5,6,7,8,9,10]) with Ab25–35 having Ca2z-mediated neurotoxic properties [11,12]. Astrocytes are known to become reactive in Alzheimer’s disease and their ionic equilibrium can be disturbed by interaction of the released and accumulated transmitters, such as serotonin, and peptides, including amyloid-b peptides (Ab). We have here studied the effects of small amounts of Ab25–35 fragments on the transmitter-induced calcium signals in astrocytes by Fura-2AM fluorescence measurements and running simulations of the detected calcium signals

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call